Lung Cancer Trial, Recruiting NCT06548711 Sponsor: Kong Fanming Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06548711
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 80 years old
  • You had surgery under general anesthesia to remove lung cancer, which may have included removal of nearby lymph nodes
  • Your removed tissue was confirmed by laboratory testing to be primary lung cancer
  • You have had a persistent dry cough for 2 weeks or longer following your lung surgery
  • You are fully conscious, able to clearly communicate, and willing to sign a consent form

Who may not be able to join:

  • You were diagnosed with an acute (sudden) respiratory illness within the past month
  • A chest X-ray has shown you have pneumonia
  • You have a history of asthma or tuberculosis
  • You have uncontrolled overactive thyroid, severe high blood pressure, heart disease, a widespread infection, a blood clotting disorder, or another serious long-term illness
  • You have taken steroid medications at any point in the past 3 months
  • You have taken a type of blood pressure medication called ACE inhibitors (such as lisinopril or ramipril) within the past 6 months
  • You have surgical wounds, skin allergies, open wounds, or skin infections in the area where treatment would be applied
  • You are unable to tolerate mild electrical stimulation applied to the skin, or you stopped tolerating it during treatment (confirm with trial site)
  • You have a medical reason why electrical stimulation cannot be used on you, or you have an implanted electrical device such as a pacemaker (confirm with trial site)
  • You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kong Fanming
Registry
ClinicalTrials.gov
Start date
17 April 2024
Est. completion
17 April 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

LCQ-MC

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov